ONCT - Oncternal Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 576.92M
Enterprise Value 336.83M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)39.45
Price/Book (mrq)N/A
Enterprise Value/Revenue 318.89
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 1.66
52-Week Change 3-96.74%
S&P500 52-Week Change 31.11%
52 Week High 3179.2000
52 Week Low 33.4300
50-Day Moving Average 34.9091
200-Day Moving Average 37.0774

Share Statistics

Avg Vol (3 month) 342.42k
Avg Vol (10 day) 317.78k
Shares Outstanding 521.86M
Float N/A
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Jul 31, 2019) 4170.66k
Short Ratio (Jul 31, 2019) 46.25
Short % of Float (Jul 31, 2019) 49.10%
Short % of Shares Outstanding (Jul 31, 2019) 41.11%
Shares Short (prior month Jun 28, 2019) 4236.95k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 27/1
Last Split Date 3Jun 10, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-474.51%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)1.95M
Revenue Per Share (ttm)0.13
Quarterly Revenue Growth (yoy)-55.90%
Gross Profit (ttm)-5.77M
EBITDA N/A
Net Income Avi to Common (ttm)-27.82M
Diluted EPS (ttm)-0.1340
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)28.52M
Total Cash Per Share (mrq)1.85
Total Debt (mrq)265k
Total Debt/Equity (mrq)1.15
Current Ratio (mrq)3.81
Book Value Per Share (mrq)-0.58

Cash Flow Statement

Operating Cash Flow (ttm)-12.01M
Levered Free Cash Flow (ttm)N/A